Midazolam suppresses glioma progression by attenuating neuronal activity and downregulating IGF1 signaling
This study demonstrates that midazolam suppresses glioma progression both in vitro and in vivo by attenuating neuronal activity, which subsequently downregulates neuron-derived IGF1 signaling and inhibits the PI3K/AKT pathway to reduce tumor growth.